Autoimmune Diseases  >>  Apidra (insulin glulisine)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Apidra (insulin glulisine) / Sanofi
NCT00546702: Glulisine + Lantus in Type I Patients

Completed
3
142
RoW
Insuline Glulisine
Sanofi
Diabetes Mellitus, Type 1
02/05
02/05
NCT00545337: Glulisine + Lantus in Type I Patients

Completed
3
60
RoW
Insuline glulisine
Sanofi
Diabetes Mellitus, Type 1
06/05
06/05
NCT00115570: Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents

Completed
3
572
US
Insulin glulisine, apidra, insulin lispro, insulin glargine, NPH insulin
Sanofi
Diabetes Mellitus, Insulin-Dependent
11/06
11/06
NCT00397553: Insulin Glulisine, Diabetes Mellitus Type 1

Completed
3
104
RoW
Insulin glulisine
Sanofi
Diabetes Mellitus, Type 1
12/07
 
VARIABILITE, NCT00271284: Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients

Completed
3
88
Europe
insulin glulisine / insulin glargine, insulin glulisin / insulin detemir
Sanofi
Diabetes Mellitus, Type 1
09/08
09/08
NCT00290979: Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus

Completed
3
250
Japan
insulin glulisine
Sanofi
Diabetes Mellitus, Type 1
 
 

Download Options